MIEBO (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) Trademark
Trademark Overview
On Thursday, January 11, 2024, a trademark application was filed for MIEBO (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) with the United States Patent and Trademark Office. The USPTO has given the MIEBO (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) trademark a serial number of 98352821. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 9, 2024. This trademark is owned by Bausch + Lomb Ireland Limited. The MIEBO (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) trademark is filed in the Pharmaceutical Products category with the following description:
Ophthalmic preparations containing perfluorohexyloctane
General Information
| Serial Number | 98352821 |
| Word Mark | MIEBO (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) |
| Filing Date | Thursday, January 11, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, September 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 15, 2024 |
Trademark Statements
| Description of Mark | The mark consists of trade dress applied to one side of three-dimensional product packaging. The background of the product packaging is blue at the top and transitions to purple towards the bottom. At the center of the packaging is the stylized word "Miebo" in white, with three diagonal white lines extending outward from the upper right portion of the letter "o". Below the word "Miebo" is the stylized wording "(perfluorohexyloctane ophthalmic solution)" in white with "perfluorohexyloctane" above "ophthalmic solution". The dotted outline of the packaging is intended to show the position of the mark and is not part of the mark. |
| Goods and Services | Ophthalmic preparations containing perfluorohexyloctane |
| Pseudo Mark | MIEBO PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION |
| Indication of Colors claimed | The color(s) purple, blue, and white is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 11, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, September 12, 2023 |
| First Use In Commerce Date | Tuesday, September 12, 2023 |
Trademark Owner History
| Party Name | Bausch + Lomb Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Dublin 24
IE |
Trademark Events
| Event Date | Event Description |
| Tuesday, May 21, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 11, 2024 | NEW APPLICATION ENTERED |
| Tuesday, May 21, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 30, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, July 3, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, July 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 9, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 9, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 9, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 9, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 23, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, July 24, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, July 26, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, July 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 26, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 26, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, July 26, 2024 | EXAMINER'S AMENDMENT ENTERED |
